Adverse events154

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 154

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	4	45	6
other	Anaemia	Blood and lymphatic system disorders	Atezolizumab	6	43	7
other	Lymphadenopathy	Blood and lymphatic system disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	3	45	3
other	Lymphadenopathy	Blood and lymphatic system disorders	Atezolizumab	0	43	0
other	Sinus tachycardia	Cardiac disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	3	45	3
other	Sinus tachycardia	Cardiac disorders	Atezolizumab	1	43	1
other	Constipation	Gastrointestinal disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	9	45	10
other	Constipation	Gastrointestinal disorders	Atezolizumab	5	43	6
other	Diarrhoea	Gastrointestinal disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	12	45	15
other	Diarrhoea	Gastrointestinal disorders	Atezolizumab	7	43	11
other	Nausea	Gastrointestinal disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	12	45	15
other	Nausea	Gastrointestinal disorders	Atezolizumab	11	43	12
other	Vomiting	Gastrointestinal disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	5	45	7
other	Vomiting	Gastrointestinal disorders	Atezolizumab	7	43	7
other	Chest pain	General disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	4	45	4
other	Chest pain	General disorders	Atezolizumab	2	43	2
other	Chills	General disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	3	45	3
other	Chills	General disorders	Atezolizumab	2	43	2
other	Fatigue	General disorders	CMB305 (Sequentially Administered LV305 and G305)+Atezolizumab	18	45	31
other	Fatigue	General disorders	Atezolizumab	10	43	11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02609984/events

API reference For AI assistants

Adverse events154

Sources 3

Read this list from software.